Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy

BACKGROUND: In clinical trials of pegloticase, a PEGylated uricase developed for treatment of gout refractory to conventional therapy, infusion-related reactions (IRs) were the second most frequent adverse event reported. OBJECTIVE: The objective of this study was to provide a detailed account of IR...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Rheumatol
Main Authors: Baraf, Herbert S. B., Yood, Robert A., Ottery, Faith D., Sundy, John S., Becker, Michael A.
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2014
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280274/
https://ncbi.nlm.nih.gov/pubmed/25417679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000200
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker